Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05398406
Other study ID # 01
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 1, 2020
Est. completion date January 1, 2021

Study information

Verified date May 2022
Source Yuzuncu Yil University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Sixty patients with ASA (American Society of Anesthesiologist) I-II physical status between the ages of 20-60 were randomized into three groups: TAP block group (Group T), ESP block group (Group E) and PVB group (Group P). Bilateral 20cc (total 40cc for each patient) 0.25% bupivacaine was applied by ultrasound (US) guidance. Intraoperative vital signs (heart rate, blood pressure, and saturation), Train-of-four (TOF) values, additional dose of opioid and muscle relaxant needs, complications were recorded. Postoperative side effects (nausea, vomiting, itching, tremor), the need for additional postoperative analgesia, Visual Analog Scale (VAS) scores were noted.


Description:

Cases; under the age of 20 - over 60, emerge and bleeding, outside the ASAI-II functional status, undergo surgery other than laparoscopic cholecystectomy, refused to participate in the study, allergic to local anesthetic agents, with a body mass index (BMI) >30, have contraindications for regional anesthesia (sepsis, local infection, coagulopathy, heart disease, hypovolemia, cases that do not want regional anesthesia), pregnant were not included in the study.Twenty patients in each group and a total of 60 patients were included the study by power analysis. According to the randomized, single-blind, closed-envelope method, patients were randomly divided into three groups. Group T (Subcostal TAP Block): 40 cc (20cc+20cc) 0.25 % Bupivacaine for bilateral application Group E (ESP Block): 40 cc (20cc+20cc) 0.25% Bupivacaine for bilateral application Group P (PVB): 40 cc (20cc+20cc) 0.25% Bupivacaine for bilateral application were prepared.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date January 1, 2021
Est. primary completion date August 1, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 60 Years
Eligibility Inclusion Criteria: - 20-60 years, - ASA I-II , - scheduled for elective laparoscopic cholecystectomy - under general anesthesia, - agreed to participate in the study, Exclusion Criteria: - under the age of 20 - over 60, - emerge and bleeding, - outside the ASAI-II functional status, - undergo surgery other than laparoscopic cholecystectomy, - refused to participate in the study, allergic to local anesthetic agents, - body mass index (BMI) >30, - have contraindications for regional anesthesia (sepsis, local infection, coagulopathy, heart disease, hypovolemia, cases that do not want regional anesthesia), - pregnant

Study Design


Related Conditions & MeSH terms


Intervention

Other:
TAP Block group
TAP Block: the US probe was placed on the imaginary line connecting the anterior superior iliac spine and the umbilicus. The ilioinguinal and iliohypogastric nerves in the fascia of the internal obliq and transverse abdominis muscles were visualized by US. A total of 40 ml of local anesthetic was infiltrated ESP Blok : a 100 mm 21G peripheral nerve block needle was inserted between the erector spinae muscle and the transverse process structures in an in-plane section guided by US from the T7-8 level. 40 ml of the prepared solutions were injected PVB: In the lateral decubitus position, the cranial to caudal transverse processes and the superior costotransverse ligament and the pleura were visualized from the T7-8 level in the in-plane section under US guidance. A 100 mm 21G peripheral nerve block needle was advanced until it passed through the superior costotransverse ligament. A total of 40 ml of injections were made
Paravertebral block group
In the lateral decubitus position, the cranial to caudal transverse processes and the superior costotransverse ligament and the pleura were visualized from the T7-8 level in the in-plane section under US guidance. A 100 mm 21G peripheral nerve block needle (SonoPlex Stim Cannula, PAJUNK®, USA) was advanced until it passed through the superior costotransverse ligament. A total of 40 ml of injections were made bilaterally in the form of 20+20 ml.
Erector spinae block group
In the lateral decubitus position, a 100 mm 21G peripheral nerve block needle (SonoPlex Stim Cannula, PAJUNK®,USA) was inserted between the erector spinae muscle and the transverse process structures in an in-plane section guided by US from the T7-8 level. A total of 40 ml of the prepared solutions were injected bilaterally as 20+20 ml.

Locations

Country Name City State
Turkey Van Yuzuncu Yil University VAN Tusba

Sponsors (1)

Lead Sponsor Collaborator
Yuzuncu Yil University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary demographic data age, gender, height, weight, and BMI 6 monthes
Primary Heart rate values Heart rate values for (-5)-0-30-40 min 6 monthes
Secondary postoperative analgesic requirement the need for postoperative analgesia 6 monthes
Secondary postoperative side effects nausea, vomiting and tremor 6 monthes
See also
  Status Clinical Trial Phase
Active, not recruiting NCT06345352 - Evaluation of the Quality of Care in the Emergency Department by Studying the Appropriateness of Admissions of Patients Accessing the Emergency Department (Fondazione IRCCS Ca' Granda Ospedale Maggione Policlinico)
Withdrawn NCT05609383 - Out-patient Discharge Management After General Intravenous Anesthesia
Active, not recruiting NCT06345378 - Evaluation of the Quality of Care in the Emergency Department by Studying the Appropriateness of Admissions of Patients Accessing the Emergency Department (ASST Papa Giovanni XXIII)
Recruiting NCT04727359 - Evaluation of a Flexible and Integrative Psychiatric Care Model in Child and Adolescent Psychiatry
Recruiting NCT06142058 - RecistTM Criteria in Evaluating the Efficacy of Targeted Therapy for NSCLC
Completed NCT03957889 - Students and Trainers' Evaluations Correlation
Recruiting NCT04676347 - Health-care Quality in Semi-intensive Care Units
Completed NCT03856333 - Cognitive Exercise Therapy Approach Scale in Patients With Chronic Neck Pain N/A
Completed NCT01479985 - Computerized Contraceptive Decision Aid N/A